ISSN: E-2314-7326
P-2314-7334

న్యూరోఇన్ఫెక్షియస్ వ్యాధులు

అందరికి ప్రవేశం

మా గ్రూప్ ప్రతి సంవత్సరం USA, యూరప్ & ఆసియా అంతటా 3000+ గ్లోబల్ కాన్ఫరెన్స్ ఈవెంట్‌లను నిర్వహిస్తుంది మరియు 1000 కంటే ఎక్కువ సైంటిఫిక్ సొసైటీల మద్దతుతో 700+ ఓపెన్ యాక్సెస్ జర్నల్‌లను ప్రచురిస్తుంది , ఇందులో 50000 మంది ప్రముఖ వ్యక్తులు, ప్రఖ్యాత శాస్త్రవేత్తలు ఎడిటోరియల్ బోర్డ్ సభ్యులుగా ఉన్నారు.

ఎక్కువ మంది పాఠకులు మరియు అనులేఖనాలను పొందే ఓపెన్ యాక్సెస్ జర్నల్స్

700 జర్నల్స్ మరియు 15,000,000 రీడర్లు ప్రతి జర్నల్ 25,000+ రీడర్లను పొందుతున్నారు

ఇండెక్స్ చేయబడింది
  • ఇండెక్స్ కోపర్నికస్
  • గూగుల్ స్కాలర్
  • J గేట్ తెరవండి
  • RefSeek
  • హమ్దార్డ్ విశ్వవిద్యాలయం
  • EBSCO AZ
  • OCLC- వరల్డ్ క్యాట్
  • క్యాబ్ డైరెక్ట్
  • పబ్లోన్స్
  • జెనీవా ఫౌండేషన్ ఫర్ మెడికల్ ఎడ్యుకేషన్ అండ్ రీసెర్చ్
  • ICMJE
ఈ పేజీని భాగస్వామ్యం చేయండి

నైరూప్య

Parkinson's Disease Associated with Cognitive Decline

Vincenza Aurelian

Increasing events or objects that prove something hints that gangliosides act as important people who try to settle an argument in both demyelination and remyelination. Goal: The purpose of the present study was to ask lots of questions about/try to find the truth about the presence of IgM disease-fighters against GM1, GD1b and GQ1b gangliosides in the sera of in patients who suffered from Parkinson's disease in relationship with the medicine-based limits/guidelines. The present research is based on the act of asking questions and trying to find the truth about something for anti-ganglioside disease-fighters and healthy age-matched people, as usual/ commonly and regular/ healthy controls, using Enzyme-Linked Immuno-Sorbent tests/things to be tested. The patients showed/told about increased levels of the tested disease-fighters, compared to usual/ commonly and regular/ healthy controls. A relationship between IgM anti-GM1 and the level of thinking-related damage/weakness Minimental State Examination; Brought together as one Parkinson's Disease Rating Scale I was also saw/heard/became aware of. An off to the side neuroimmune response may happen in patients who suffer from Parkinson's disease especially those with thinking-related damage/weakness. Further (act of asking questions and trying to find the truth about something) is needed to establish a direct connection between that unable to be harmed response and disease how a disease works. One of the most impactful non-motor visible signs of Parkinson's disease (PD) is thinking-related damage/weakness. Thinking-related decline in PD exists as a (something that continues from one extreme to the other), with signs of sickness ranging from (usual/ commonly and regular/ healthy) thinking to mild thinking-related damage/weakness (MCI) and finally severe problems with thinking and living (PDD). MCI is related to medicine and science group of different things mixed together and its development or increase over time/series of events or things differs/changes with cases returning to usual/ commonly and regular/ healthy thinking. Opposite from what's expected, when severe problems with thinking and living happens, the decline is usually fast and made a prejudiced mental picture. The combination of Lewy and Brain disease disease/the study of disease is the most strong and healthy disease-related relate of PDD. There are no approved drugs for PD-MCI and the benefit from the only approved showing signs of sickness treatment for PDD is modest.